Global Arthritis Monoclonal Antibodies Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Market Analysis by Type
  • 1.3.1 Global Arthritis Monoclonal Antibodies Market Size Growth Rate by Type: 2020 VS 2026
  • 1.3.2 Remicade
  • 1.3.3 Humira
  • 1.3.4 Enbrel
  • 1.3.5 Rituxan
  • 1.3.6 Orencia
  • 1.3.7 Actemra
  • 1.3.8 Simponi
  • 1.3.9 Cimzia
• 1.4 Market by Application
  • 1.4.1 Global Arthritis Monoclonal Antibodies Market Share by Application: 2020 VS 2026
  • 1.4.2 Rheumatoid Arthritis
  • 1.4.3 Osteoarthritis
  • 1.4.4 Psoriatic Arthritis
  • 1.4.5 Ankylosing Spondylitis
  • 1.4.6 Fibromyalgia
  • 1.4.7 Others
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Arthritis Monoclonal Antibodies Market Perspective (2015-2026)
• 2.2 Arthritis Monoclonal Antibodies Growth Trends by Regions
  • 2.2.1 Arthritis Monoclonal Antibodies Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Arthritis Monoclonal Antibodies Historic Market Share by Regions (2015-2020)
  • 2.2.3 Arthritis Monoclonal Antibodies Forecasted Market Size by Regions (2021-2026)
• 2.3 Arthritis Monoclonal Antibodies Industry Dynamic
  • 2.3.1 Arthritis Monoclonal Antibodies Market Trends
  • 2.3.2 Arthritis Monoclonal Antibodies Market Drivers
  • 2.3.3 Arthritis Monoclonal Antibodies Market Challenges
  • 2.3.4 Arthritis Monoclonal Antibodies Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Arthritis Monoclonal Antibodies Players by Market Size
  • 3.1.1 Global Top Arthritis Monoclonal Antibodies Players by Revenue (2015-2020)
  • 3.1.2 Global Arthritis Monoclonal Antibodies Revenue Market Share by Players (2015-2020)
• 3.2 Global Arthritis Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Arthritis Monoclonal Antibodies Revenue
• 3.4 Global Arthritis Monoclonal Antibodies Market Concentration Ratio
  • 3.4.1 Global Arthritis Monoclonal Antibodies Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Arthritis Monoclonal Antibodies Revenue in 2019
• 3.5 Key Players Arthritis Monoclonal Antibodies Area Served
• 3.6 Key Players Arthritis Monoclonal Antibodies Product Solution and Service
• 3.7 Date of Enter into Arthritis Monoclonal Antibodies Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Arthritis Monoclonal Antibodies Breakdown Data by Type

• 4.1 Global Arthritis Monoclonal Antibodies Historic Market Size by Type (2015-2020)
• 4.2 Global Arthritis Monoclonal Antibodies Forecasted Market Size by Type (2021-2026)

5 Arthritis Monoclonal Antibodies Breakdown Data by Application

• 5.1 Global Arthritis Monoclonal Antibodies Historic Market Size by Application (2015-2020)
• 5.2 Global Arthritis Monoclonal Antibodies Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Arthritis Monoclonal Antibodies Market Size (2015-2026)
• 6.2 North America Arthritis Monoclonal Antibodies Market Size by Type (2015-2020)
• 6.3 North America Arthritis Monoclonal Antibodies Market Size by Application (2015-2020)
• 6.4 North America Arthritis Monoclonal Antibodies Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Arthritis Monoclonal Antibodies Market Size (2015-2026)
• 7.2 Europe Arthritis Monoclonal Antibodies Market Size by Type (2015-2020)
• 7.3 Europe Arthritis Monoclonal Antibodies Market Size by Application (2015-2020)
• 7.4 Europe Arthritis Monoclonal Antibodies Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Arthritis Monoclonal Antibodies Market Size (2015-2026)
• 8.2 Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Type (2015-2020)
• 8.3 Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Application (2015-2020)
• 8.4 Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia

9 Latin America

• 9.1 Latin America Arthritis Monoclonal Antibodies Market Size (2015-2026)
• 9.2 Latin America Arthritis Monoclonal Antibodies Market Size by Type (2015-2020)
• 9.3 Latin America Arthritis Monoclonal Antibodies Market Size by Application (2015-2020)
• 9.4 Latin America Arthritis Monoclonal Antibodies Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Arthritis Monoclonal Antibodies Market Size (2015-2026)
• 10.2 Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Type (2015-2020)
• 10.3 Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Application (2015-2020)
• 10.4 Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE

11Key Players Profiles

• 11.1 AbbVie Inc
  • 11.1.1 AbbVie Inc Company Details
  • 11.1.2 AbbVie Inc Business Overview
  • 11.1.3 AbbVie Inc Arthritis Monoclonal Antibodies Introduction
  • 11.1.4 AbbVie Inc Revenue in Arthritis Monoclonal Antibodies Business (2015-2020))
  • 11.1.5 AbbVie Inc Recent Development
• 11.2 F. Hoffmann-La Roche Ltd
  • 11.2.1 F. Hoffmann-La Roche Ltd Company Details
  • 11.2.2 F. Hoffmann-La Roche Ltd Business Overview
  • 11.2.3 F. Hoffmann-La Roche Ltd Arthritis Monoclonal Antibodies Introduction
  • 11.2.4 F. Hoffmann-La Roche Ltd Revenue in Arthritis Monoclonal Antibodies Business (2015-2020)
  • 11.2.5 F. Hoffmann-La Roche Ltd Recent Development
• 11.3 Novartis
  • 11.3.1 Novartis Company Details
  • 11.3.2 Novartis Business Overview
  • 11.3.3 Novartis Arthritis Monoclonal Antibodies Introduction
  • 11.3.4 Novartis Revenue in Arthritis Monoclonal Antibodies Business (2015-2020)
  • 11.3.5 Novartis Recent Development
• 11.4 Johnson & Johnson(Janssen)
  • 11.4.1 Johnson & Johnson(Janssen) Company Details
  • 11.4.2 Johnson & Johnson(Janssen) Business Overview
  • 11.4.3 Johnson & Johnson(Janssen) Arthritis Monoclonal Antibodies Introduction
  • 11.4.4 Johnson & Johnson(Janssen) Revenue in Arthritis Monoclonal Antibodies Business (2015-2020)
  • 11.4.5 Johnson & Johnson(Janssen) Recent Development
• 11.5 Pfizer Inc
  • 11.5.1 Pfizer Inc Company Details
  • 11.5.2 Pfizer Inc Business Overview
  • 11.5.3 Pfizer Inc Arthritis Monoclonal Antibodies Introduction
  • 11.5.4 Pfizer Inc Revenue in Arthritis Monoclonal Antibodies Business (2015-2020)
  • 11.5.5 Pfizer Inc Recent Development
• 11.6 Mylan
  • 11.6.1 Mylan Company Details
  • 11.6.2 Mylan Business Overview
  • 11.6.3 Mylan Arthritis Monoclonal Antibodies Introduction
  • 11.6.4 Mylan Revenue in Arthritis Monoclonal Antibodies Business (2015-2020)
  • 11.6.5 Mylan Recent Development
• 11.7 Genentech
  • 11.7.1 Genentech Company Details
  • 11.7.2 Genentech Business Overview
  • 11.7.3 Genentech Arthritis Monoclonal Antibodies Introduction
  • 11.7.4 Genentech Revenue in Arthritis Monoclonal Antibodies Business (2015-2020)
  • 11.7.5 Genentech Recent Development
• 11.8 GSK
  • 11.8.1 GSK Company Details
  • 11.8.2 GSK Business Overview
  • 11.8.3 GSK Arthritis Monoclonal Antibodies Introduction
  • 11.8.4 GSK Revenue in Arthritis Monoclonal Antibodies Business (2015-2020)
  • 11.8.5 GSK Recent Development
• 11.9 AstraZeneca PLC
  • 11.9.1 AstraZeneca PLC Company Details
  • 11.9.2 AstraZeneca PLC Business Overview
  • 11.9.3 AstraZeneca PLC Arthritis Monoclonal Antibodies Introduction
  • 11.9.4 AstraZeneca PLC Revenue in Arthritis Monoclonal Antibodies Business (2015-2020)
  • 11.9.5 AstraZeneca PLC Recent Development

12Analyst's Viewpoints/Conclusions

13Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer